Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-26

Clinical Trial Update: The Effects of DHA on Attention Deficit and Hyperactivity Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial update on the effects of DHA in Attention Deficit Hyperactivity Disorder (ADHD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IRCCS Eugenio Medea | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED